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Abstract
Background—Prospective cohort studies have indicated that serum vitamin D levels are 
inversely related to risk of type 2 diabetes. However, such studies cannot determine the source of 
vitamin D. Therefore, we examined the association of dietary vitamin D intake with incident type 
2 diabetes within the European Prospective Investigation into Cancer and Nutrition (EPIC)-
InterAct study in a heterogeneous European population including 8 countries with large 
geographical variation.
Methods—Using a case-cohort design, 11,245 incident cases of type 2 diabetes and a 
representative subcohort (N=15,798) were included in the analyses. Hazard ratios (HR) and 95% 
confidence intervals (CIs) for type 2 diabetes were calculated using a Prentice-weighted Cox 
regression adjusted for potential confounders. 24-h diet recall data from a subsample (N=2347) 
were used to calibrate habitual intake data derived from dietary questionnaires.
Results—Median follow-up time was 10.8 years. Dietary vitamin D intake was not significantly 
associated with the risk of type 2 diabetes. HR and 95 % CIs for the highest compared to the 
lowest quintile of uncalibrated vitamin D intake was 1.09 (0.97-1.22), (ptrend=0.17). No 
associations were observed in a sex-specific analysis. The overall pooled effect [HR (95% CI)] 
using the continuous calibrated variable was 1.00 (0.97-1.03) per increase of 1 μg/day dietary 
vitamin D.
Conclusion—This observational study does not support an association between higher dietary 
vitamin D intake and type-2 diabetes incidence. This result has to be interpreted in light of the 
limited contribution of dietary vitamin D on the overall vitamin D status of a person.
Keywords
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Introduction
Besides the ‘classical’ function of vitamin D in calcium homeostasis, additional biological 
effects of vitamin D on diabetes-related outcomes have been identified. The results of 
experimental cell, animal and human studies support a role of vitamin D in the prevention of 
type 2 diabetes.1-4 However, the mechanisms by which vitamin D may affect type 2 diabetes 
risk are not fully understood. Effects of vitamin D on insulin secretion, insulin sensitivity as 
well as on inflammatory and autoimmune conditions associated with diabetic conditions are 
reported.4-9
Evidence from prospective observational studies for an inverse association between vitamin 
D status, as characterized by serum 25-hydroxyvitamin D [25(OH)D] measurements, and 
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type 2 diabetes is strong.10-12 After combining the data from nine prospective studies that 
measured serum 25(OH)D, participants in the highest (versus lowest) quartile of 25(OH)D 
showed a 41% (95% CI, 33%, 48%) lower risk of type-2 diabetes though any causal 
inference of this association remains unconfirmed.13 Moreover, a recent metaanalysis 
combining results from 14 observational studies reported a significant inverse association 
for circulating 25(OH)D but not for dietary vitamin D.14 Serum 25(OH)D concentration, the 
accepted biomarker of vitamin D status, reflects both the endogenous synthesis in the skin 
(following UVB exposure) and the dietary intake of vitamin D. Though in general the 
contribution of dietary vitamin D to the overall vitamin D status is of minor importance as 
compared to the endogenous synthesis of vitamin D, intra- and inter-subject variation in 
UVB exposure can be high, and the importance of vitamin D from diet substantially 
increases in situations with limited UVB exposure. Thus, analyses on the impact of dietary 
vitamin D and diabetes risk are meaningful. Mitri and colleagues combined data from three 
cohort studies and found a borderline significant inverse association between vitamin D 
intake >500 U/d (12.5 μg/d) and type 2 diabetes incidence (versus subjects with a vitamin D 
intake < 200 U/d (5 μg/d)); the relative risk was 0.87 (95% CI, 0.76-0.99).11 However, only 
one out of three cohort studies reported a significant inverse association.15-17
Due to its large sample size, the InterAct project within the European Prospective 
Investigation into Cancer and Nutrition (EPIC) provides the opportunity to investigate the 
association between the incidence of type 2 diabetes and dietary vitamin D prospectively in 
both men and women. Furthermore, the study allows a relatively wide range of dietary 
intake levels since data from different European countries are included.
Material and Methods
Study design and population
EPIC is a multi-centre prospective cohort study conducted since 1992 in 10 European 
countries.18 In the present EPIC-InterAct study, a nested case-cohort design within 8 of the 
10 countries contributing to the EPIC cohort was used.19 The current analysis is based on 
data from EPIC participants in Denmark, France, Germany, Italy, the Netherlands, Spain, 
Sweden, and the United Kingdom (UK).
Following the case-cohort design, the study population consisted of a random baseline 
sample of 16.154 participants (subcohort) and 12.403 incident cases of type 2 diabetes 
(including 778 from the subcohort), i.e. all participants of the entire cohort with a first 
diagnosis of type 2 diabetes between recruitment and December 31, 2007.19
The final study sample after excluding participants without dietary information (N=736) 
consisted of 27,043 participants, including 15,798 members of the subcohort and 11,994 
incident diabetes cases (including 749 cases from the subcohort).
Dietary assessment
Diet over the previous twelve months was assessed using dietary assessment instruments 
that were specifically developed for each participating country.18 The questions were 
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structured by common food groups except for the questionnaires used in Italy and Spain, 
where questions were structured by country-specific meals.
All participants were asked to report their average consumption of each food by structured 
categories ranging from never or less than once per month to six or more times per day. In 
Germany, Italy, The Netherlands and Spain individual average portions were estimated, 
whereas standard portions were assigned to the participants in Denmark, the United 
Kingdom and Umeå, Sweden. A combination of methods for estimating portion size was 
used in Malmo, Sweden. All dietary measurement instruments have been validated 
previously in a series of studies within the various source populations participating in 
EPIC.20
Daily intake of vitamin D, calcium, and magnesium was calculated by means of a 
standardized food composition data base across EPIC countries 21.
Demographic and lifestyle factors
To collect information on education, medical history (surgeries and previous illnesses), 
tobacco and alcohol consumption, and physical activity and other lifestyle factors, additional 
questionnaires were used. Height and weight were measured at baseline, except for the 
France and Oxford-UK study centre, where height and weight was self-reported.18
Ascertainment of type 2 diabetes
Ascertainment and verification of incident diabetes has been described in detail elsewhere.19 
In brief, incident cases were identified by self-reports (history of diabetes, physician-
diagnosed diabetes, antidiabetic drug use), linkage to primary and secondary care registers, 
linkage to drug registers, hospital admissions and mortality data. Further verification of the 
diabetic cases came from individual medical record reviews.
Statistical analysis
Cox proportional hazard models adapted for case-cohort design according to the Prentice 
method were used to calculate hazard ratios (HR) and 95% confidence intervals (CI).22 A 
Cox model was used with stratification by age (in 1-year categories), centre and sex; 
Incident type 2 diabetes was the outcome variable and age was used as the underlying 
timescale.
Hazard ratios for dietary vitamin D intake are presented comparing quintiles taking the 
lowest quintile as reference. Quintile cutpoints were defined among subcohort members 
only. Different models were run to disentangle the effects of dietary vitamin D on type 2 
diabetes: model 1: adjusted for total energy (kcal/day, cont.); model 2: adjusted for non-fat-
energy (kcal/day, cont.), fat (g/day, cont., monounsaturated, polyunsaturated and saturated 
fat), physical activity (occupational, recreational and household activity; inactive, 
moderately inactive, moderately active, active, missing)23, and model 3: as model 2 with 
further adjustment for a-priori defined potential confounders and risk factors for diabetes: 
BMI (kg/m2, cont.), education level (none or primary school, technical/professional school, 
secondary school, longer education incl. university degree, unknown), smoking status 
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(never, former, current, unknown), alcohol intake (g/day, cont.). Sensitivity analyses were 
performed excluding incident cases that occurred within the first two years of follow-up as 
well as additional adjustment for waist-hip-ratio.
In order to account for different levels of sunlight exposure, the EPIC centres were divided 
into 7 latitude group: below 42°N (Granada, Murcia, Ragusa, and Naples); 42°N - 44°N 
(Asturias, Navarra, San Sebastian, Florence, and South coast of France – centred in 
Marseille); 45°N - 46°N (Varese, Turin, and South of France – centred in Lyon); 47°N - 
49°N (North-East and West of France – centred in Nantes and Paris, respectively – and 
Heidelberg); 50°N - 51°N (Potsdam, Utrecht, Bilthoven, Cambridge, and Oxford); 52°N - 
56°N (Malmö, Aarhus, and Copenhagen); and above 57°N (Norway, and Umeå). A further 
sensitivity analysis was thus performed with additional adjustment for latitude.
Statistical interaction (heterogeneity) was evaluated with the Wald test by including cross-
product terms of potential interaction variables (i.e., sex, physical activity, BMI) in the 
respective models. Tests for trend over quintiles of intake (coded 1 to 5) were performed 
using the Wald statistics.
To correct for measurement error, dietary intake data calculated from questionnaire data 
were calibrated against 24 hour dietary recall data for a subsample (N = 2347). A fixed-
effects linear model was used in which centre and sex-specific recall data were regressed on 
the dietary intakes.24-26 The calibrated dietary data were used to model dietary intake of 
vitamin D continuously in the whole sample and in the country-specific analysis. We used a 
meta-analytic approach to investigate heterogeneity across centres (metan procedure in 
STATA) by pooling the adjusted HR’s per centre using the random effects model.
All tests were two-sided and considered to be statistically significant with a p-value of 
≤0.05. All analyses were conducted using SAS version 9.1 (SAS Institute, Cary, North 
Carolina) and STATA version 10 for meta-analysis (College Station, Texas).
Results
Median vitamin D intake in the subcohorts of the respective countries by sex is shown in 
Table 1. Dietary vitamin D intake was highest in Sweden and lowest in Italy. Vitamin D 
intake was higher in men across all countries.
Median age at baseline was 52.7 years (IQR 46.5-59.2). The median follow-up time for the 
study population was 10.8 years. Descriptive characteristics of the subcohort by quintiles of 
vitamin D intake are shown in Table 2. The percentage of current smokers was lower in men 
but higher in women with higher vitamin D intake. The increasing numbers of participants 
with unknown physical activity with increasing vitamin D intake is due to physical activity 
data not being collected in Umeå, Sweden, where vitamin D intake is high. No differences in 
BMI were observed by quintiles of vitamin D intake. Total fish, meat, calcium and energy 
intake was higher in both men and women with increasing vitamin D intake (table 2).
No significant association was observed between vitamin D intake and type 2 diabetes risk 
(Table 3). Hazard ratios (HR) and 95 % confidence intervals (CI) in the most adjusted model 
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for the higher quintiles compared to the lowest were 1.04 (0.95-1.14), 1.02 (0.93-1.12), 1.06 
(0.96-1.17) and 1.09 (0.97-1.22) (p-trend=0.17) (Table 3). We further performed a separate 
analysis by sex and did not find any significant association between diabetes incidence and 
vitamin D intake in either men or women (pinteraction = 0.40). No statistical interaction was 
observed between BMI or physical activity groups and dietary vitamin D (pinteraction> 0.05). 
Moreover, there was no statistical interaction between vitamin D and calcium intake (p = 
0.93).
To account for potential measurement error when calculating dietary intake from 
questionnaire data, we further performed an analysis using the continuous intake data 
calibrated with 24-hr dietary recall data from a subsample of the subcohort. The overall 
estimate showed no association for vitamin D and diabetes risk [HR (95% CI) =1.00 
(0.97-1.03), per 1 μg/day increment] (Figure 1). The corresponding effect estimate using the 
observed (continuous) data was HR (95% CI) =1.03 (0.98-1.08). Country specific hazard 
ratios for the calibrated vitamin D intake (per 1 μg/day increment) in comparison with the 
overall effect estimate are shown in the forest plot (Figure 1). There was statistically 
significant heterogeneity across countries (I2=60.9%, p = 0.012). Heterogeneity could in part 
be explained by the significant positive association in the UK data as exclusion of the UK 
data resulted in a non-significant and substantially decreased heterogeneity (I2=18.6%, p = 
0.228). In a sensitivity analysis, we excluded incident cases that occurred within the first two 
years of follow-up. No considerable changes in the hazard ratios were observed. We 
furthermore additionally adjusted for waist-hip-ratio and did not observe any changes in the 
effect estimates (waist-hip-ratio data are missing for the Umeå centre, n = 1796). As a proxy 
for sun exposure and thus endogenous vitamin D production we divided the centres in 7 
categories according to their latitude. Adjustment for latitude did not notably change the 
observed risk estimates for vitamin D and typ-2 diabetes risk. Furthermore, additional 
adjustment for calcium intake did not notably change the risk estimates.
Discussion
In this large prospective case-cohort analysis within the European Prospective Investigation 
into Cancer and Nutrition dietary vitamin D was not significantly associated with the 
incidence of type 2 diabetes. This was true for men and women. So far, only few cohort 
studies prospectively assessed the association between dietary vitamin D with the incidence 
of type 2 diabetes or diabetes related outcomes.15-17 In line with our results, the Nurses’ 
Health Study did not find a significant association between dietary or total intake of vitamin 
D and type 2 diabetes.16 Furthermore, our results corroborate the findings from a large 
Japanese cohort that reported no association in men or in women.17 However, the Women’s 
Health Study reported an inverse association between dietary vitamin D intake and the 
prevalence of metabolic syndrome15, and also a meta-analysis of these three studies found a 
borderline inverse association between vitamin D intake >500 U/d (>12.5 μg/d) and type 2 
diabetes incidence.11
Systematic reviews focusing on eight randomized trials did also not provide clear evidence 
for an inverse association of vitamin D supplementation with hyperglycemia or incident type 
2 diabetes.11 The so far largest trial, the Women’s Health Initiative (WHI) study, did not 
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observe any risk reduction of type 2 diabetes over 7 years of follow-up in the intervention 
arm with supplementation of vitamin D (400 IU/d) and calcium (1000 mg/d).27 However, 
the authors noted, that higher doses of vitamin D may have been necessary to affect diabetes 
risk. Several explanations are possible as to why we did not observe any association between 
dietary vitamin D and type 2 diabetes risk in our study: 1) there is indeed no relationship; 2) 
the amount and variation of dietary vitamin D intake is too low in the population to detect 
potential effects; especially, dietary vitamin D intake is distinctly lower in most European 
countries as compared to the US where staple food is frequently fortified with vitamin D, 
and thus dietary vitamin D intake more effectively impacts on the overall vitamin D status of 
a person.
The present study is thus far the largest study prospectively assessing the association 
between dietary vitamin D intake and the risk of type 2 diabetes. Thus, power was high to 
detect even weak associations. Further strengths of the study were the high quality of 
physician-verified diagnoses of type 2 diabetes; the calibration of nutrient intake data from 
questionnaires with that from 24 h recall data; and the inclusion of detailed information on 
potential confounders in the analysis. However, due to the observational study design, 
residual confounding cannot completely be ruled out. A further strength of the study is the 
wide range of intake from different European countries with different eating habits. The 
intake data in our study was comparable to that in representative studies in Europe.28-30 
Particularly, the here presented higher intake in the northern European countries, e.g. 
Sweden, where intake of vitamin D-rich foods and the contribution from fortified foods is 
high, is in line with previous reports.28,31 There are, however, several limitations that should 
be noted when interpreting the results. Firstly, we did not account for vitamin D from 
supplements. Additional adjustment on unspecified supplement intake in the study 
population did not change the risk estimates, but calculated amounts of vitamin D from 
supplements were not available. Secondly, the contribution of endogenous production of 
vitamin D (following UVB exposure) could not be addressed here. In a sensitivity analysis, 
we adjusted for centers’ latitude as a proxy for sun exposure, which did not affect the risk 
estimates. However, since the contribution of diet to the overall vitamin D status of a person 
is low, studies with information on the entire vitamin D status may lead to a different 
conclusion. Indeed, prospective observational studies with serum 25(OH)D measurements 
showed a strong inverse association between vitamin D status and type 2 diabetes.10-13 
However, these studies can also be subject to substantial residual confounding, e.g. by 
imprecise assessment of outdoor physical activities which are correlated with both UVB 
exposure and, eventually, with vitamin D status as well as with diabetes risk. In summary, in 
the present study we did not observe an association between dietary vitamin D intake and 
the risk of type 2 diabetes in a large European study population. However, it has to be 
acknowledged that endogenous production of vitamin D in the skin following UVB 
exposure is the dominant predictor of vitamin D status in humans.
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FIGURE 1. Dietary vitamin D intake (per 1 μg/day) and risk of type 2 diabetes, by country and 
overall: the EPIC-InterAct study; CI = confidence interval.
(Models stratified by sex and age; adjusted for non-fat energy, polyunsaturated fatty acids, 
monounsaturated fatty acids, saturated fatty acids, physical activity, education, BMI, 
smoking, alcohol intake.)
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TABLE 1
Dietary vitamin D intake by sex and country in the subcohort
1
: the EPIC-InterAct study
Country
Men Women
Median IQR Median IQR
All 3.6 1.6-7.7 2.4 1.1-4.6
France -- -- 1.3 0.7-2.5
Italy 1.3 0.8-2.7 1.0 0.5-2.1
Spain 2.7 1.3-8.7 1.7 0.9-4.4
UK 3.5 1.7-5.2 2.4 1.7-3.8
Netherlands 3.4 2.3-7.4 2.5 1.8-3.9
Germany 2.0 1.1-3.6 1.5 0.8-3.3
Sweden 7.1 4.5-9.6 4.7 3.3-6.7
Denmark 2.9 1.4-7.7 1.7 1.0-3.9
1
Vitamin D intake in μg/day from 24-hour recall data (N =2347); IQR, inter-quartile range
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